Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Renal transplantation in HIV-infected patients: experience at a tertiary hospital in Spain and review of the literature.

Gómez V, Fernández A, Galeano C, Oliva J, Diez V, Bueno C, Hevia V, Burgos FJ.

Transplant Proc. 2013 Apr;45(3):1255-9. doi: 10.1016/j.transproceed.2013.02.032. Review.

PMID:
23622672
2.

[Renal transplantation in HIV-infected patients in Spain].

Mazuecos A, Pascual J, Gómez E, Sola E, Cofán F, López F, Puig-Hooper CE, Baltar JM, González-Molina M, Oppenheimer F, Marcén R, Rivero M.

Nefrologia. 2006;26(1):113-20. Spanish.

3.

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.

Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL.

Transplantation. 2003 Jul 27;76(2):370-5.

PMID:
12883195
4.

[Prevalence of HIV-1-infection in dialysis units in Spain and potential candidates for renal transplantation: results of a Spanish survey].

Barril G, Trullás JC, González-Parra E, Moreno A, Bergada E, Jofre R, Martínez-Ara J, de Sequera P, Oliver JA, Arrieta J, Miró JM.

Enferm Infecc Microbiol Clin. 2005 Jun-Jul;23(6):335-9. Spanish.

PMID:
15970165
5.

Renal replacement therapy in patients with HIV infection in a European region: outcomes following renal transplantation.

Mazuecos A, Rodriguez Benot A, Moreno A, Burgos D, Aguera M, Garcia Alvarez T, Hernandez D, Navarro D, Castro P.

Transplant Proc. 2012 Sep;44(7):2053-6. doi: 10.1016/j.transproceed.2012.07.082.

PMID:
22974907
6.

[Renal transplantation in patients with HIV infection].

Trullás JC, Miró JM, Barril G, Ros S, Burgos FJ, Moreno A, Mazuecos A, Alvarez-Vijande R, Oppenheimer F, Carmen Sánchez M, Blanco JL, Tuset M, Torre-Cisneros J, Polo R, González J.

Enferm Infecc Microbiol Clin. 2005 Jun-Jul;23(6):363-74. Review. Spanish.

PMID:
15970170
7.

Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates.

Gruber SA, Doshi MD, Cincotta E, Brown KL, Singh A, Morawski K, Alangaden G, Chandrasekar P, Losanoff JE, West MS, El-Amm JM.

Transplantation. 2008 Jul 27;86(2):269-74. doi: 10.1097/TP.0b013e318177884e.

PMID:
18645490
8.

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.

Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG.

Am J Transplant. 2008 Feb;8(2):355-65. Epub 2007 Dec 18. Erratum in: Am J Transplant.2008 May;8(5): 1081.

9.

High incidence of delayed graft function in HIV-infected kidney transplant recipients.

Mazuecos A, Fernandez A, Zarraga S, Andres A, Rodriguez-Benot A, Jimenez C, Gomez E, Paul J, Jimeno L, Fernandez C, Burgos D, Sanchez-Fructuoso A, Guirado L.

Transpl Int. 2013 Sep;26(9):893-902. doi: 10.1111/tri.12147. Epub 2013 Jul 11.

10.

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.

Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, Shakil O, Fung JJ.

Liver Transpl. 2003 Mar;9(3):239-47.

11.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
12.

Kidney transplantation and waiting list for renal transplantation for human immunodeficiency virus patients.

Martina MN, Cofan F, Suarez A, Masso E, Trullas JC, Cervera C, Moreno A, Oppenheimer F, Miiro JM, Campistol JM.

Transplant Proc. 2011 Jul-Aug;43(6):2179-81. doi: 10.1016/j.transproceed.2011.05.024.

PMID:
21839227
13.

[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Spanish.

PMID:
22633764
14.

Liver transplantation in HIV-infected recipients.

Moreno S, Fortún J, Quereda C, Moreno A, Pérez-Elías MJ, Martín-Dávila P, de Vicente E, Bárcena R, Quijano Y, García M, Nuño J, Martínez A.

Liver Transpl. 2005 Jan;11(1):76-81.

16.

Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience.

Vernadakis S, Sotiropoulos GC, Brokalaki EI, Esser S, Kaiser GM, Cicinnati VR, Beckebaum S, Paul A, Mathé Z.

Eur J Med Res. 2011 Aug 8;16(8):342-8.

17.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
18.

Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.

Vicari AR, Spuldaro F, Sandes-Freitas TV, Cristelli MP, Requião-Moura LR, Reusing JO Jr, Pierrotti LC, Oliveira ML, Girão CM, Gadonski G, Kroth LV, Deboni LM, Ferreira GF, Tedesco-Silva H, Esmeraldo R, David-Neto E, Saitovitch D, Keitel E, Garcia VD, Pacheco-Silva A, Medina-Pestana JO, Manfro RC.

Transpl Infect Dis. 2016 Oct;18(5):730-740. doi: 10.1111/tid.12592. Epub 2016 Sep 26.

PMID:
27503081
19.

Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).

Jaén A, Esteve A, Miró JM, Tural C, Montoliu A, Ferrer E, Riera M, Segura F, Force L, Sued O, Vilaró J, Garcia I, Masabeu A, Altès J, Coltet B, Podzamczer D, Murillas J, Navarro G, Gatell JM, Casabona J; PISCIS Study Group.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):212-20.

PMID:
18297762
20.

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.

Merchante N, Girón-González JA, González-Serrano M, Torre-Cisneros J, García-García JA, Arizcorreta A, Ruiz-Morales J, Cano-Lliteras P, Lozano F, Martínez-Sierra C, Macías J, Pineda JA; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.

AIDS. 2006 Jan 2;20(1):49-57.

PMID:
16327319

Supplemental Content

Support Center